X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
humans (22) 22
hematology (19) 19
oncology (19) 19
female (10) 10
aged (9) 9
lymphoma, mantle-cell - therapy (9) 9
male (9) 9
mantle cell lymphoma (9) 9
middle aged (9) 9
aged, 80 and over (8) 8
non-hodgkins-lymphoma (8) 8
prognosis (8) 8
immunochemotherapy (7) 7
rituximab (7) 7
adult (6) 6
lymphoma, mantle-cell - mortality (6) 6
lymphoma, mantle-cell - pathology (6) 6
neoplasm staging (6) 6
prospective randomized-trial (6) 6
treatment outcome (6) 6
abridged index medicus (5) 5
cyclophosphamide (5) 5
high-dose therapy (5) 5
lymphoma, mantle-cell - diagnosis (5) 5
progression-free survival (5) 5
survival (5) 5
therapy (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
chronic lymphocytic-leukemia (4) 4
combined modality therapy (4) 4
europe (4) 4
lymphoma, mantle-cell - drug therapy (4) 4
medicin och hälsovetenskap (4) 4
survival analysis (4) 4
transplantation (4) 4
cancer (3) 3
cancer och onkologi (3) 3
care and treatment (3) 3
cell proliferation (3) 3
clinical trials as topic (3) 3
cyclophosphamide - administration & dosage (3) 3
disease-free survival (3) 3
elderly-patients (3) 3
klinisk medicin (3) 3
life sciences (3) 3
medical and health sciences (3) 3
methods (3) 3
retrospective studies (3) 3
age factors (2) 2
aging (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
article (2) 2
b-cell lymphoma (2) 2
biomarkers, tumor - analysis (2) 2
bone-marrow-transplantation (2) 2
cancer and oncology (2) 2
cell transformation, neoplastic - genetics (2) 2
central nervous system (2) 2
clinical medicine (2) 2
cohort studies (2) 2
cyclophosphamide - adverse effects (2) 2
diffuse large b-cell lymphoma (2) 2
doxorubicin - administration & dosage (2) 2
doxorubicin - adverse effects (2) 2
europe - epidemiology (2) 2
expression (2) 2
fludarabine (2) 2
follicular lymphoma (2) 2
follow-up studies (2) 2
gene-expression (2) 2
genomics (2) 2
health aspects (2) 2
immunohistochemistry (2) 2
indolent lymphoma (2) 2
international prognostic index (2) 2
kaplan-meier estimate (2) 2
ki-67 antigen - analysis (2) 2
leukocyte count (2) 2
long-term remission (2) 2
low-grade lymphoma (2) 2
lymphoma, mantle-cell - etiology (2) 2
lymphoma, mantle-cell - genetics (2) 2
lymphomas (2) 2
medicine, general & internal (2) 2
minimal residual disease (2) 2
molecular pathogenesis (2) 2
multivariate analysis (2) 2
neoplasm recurrence, local - diagnosis (2) 2
neoplasm recurrence, local - therapy (2) 2
non-hodgkins-lymphomas (2) 2
phase-ii trial (2) 2
positron-emission-tomography (2) 2
predictive value of tests (2) 2
prednisone - administration & dosage (2) 2
prednisone - adverse effects (2) 2
proportional hazards models (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Alexanov, Ludmil B and Nik-Zainal, Serena and Wedge, David C and Aparicio, Samuel A. J. R and Behjati, Sam and Biankin, Anew V and Bignell, Graham R and Bolli, Niccolò and Borg, Ake and Børresen-Dale, Anne-Lise and Boyault, Sanine and Burkhardt, Birgit and Butler, Adam P and Caldas, Carlos and Davies, Helen R and Desmedt, Christine and Eils, Roland and Eyfjörd, Jórunn Erla and Foekens, John A and Greaves, Mel and Hosoda, Fumie and Hutter, Barbara and Ilicic, Tomislav and Imbeaud, Sanine and Imielinsk, Marcin and Jäger, Natalie and Jones, David T. W and Jones, David and Knappskog, Stian and Kool, Marcel and Lakhani, Sunil R and López-Otín, Carlos and Martin, Sancha and Munshi, Nikhil C and Nakamura, Hiromi and Northcott, Paul A and Pajic, Marina and Papaemmanuil, Elli and Paradiso, Angelo and Pearson, John V and Puente, Xose S and Raine, Keiran and Ramakrishna, Manasa and Richardson, Anea L and Richter, Julia and Rosenstiel, Philip and Schlesner, Matthias and Schumacher, Ton N and Span, Paul N and Teague, Jon W and Totoki, Yasushi and Tutt, Anew N. J and Valdés-Mas, Rafael and van Buuren, Marit M and van 't Veer, Laura and Vincent-Salomon, Anne and Waddell, Nicola and Yates, Lucy R and Zucman-Rossi, Jessica and Futreal, P. Anew and McDermott, Ultan and Lichter, Peter and Meyerson, Matthew and Grimmond, Sean M and Siebert, Reiner and Campo, Elías and Shibata, Tatsuhiro and Pfister, Stefan M and Campbell, Peter J and Stratton, Michael R and Claviez, Alexander and Rosenwald, Aneas and Borkhardt, Arndt and Brors, Benedikt and Radlwimmer, Bernhard and Lawerenz, Chris and Lopez, Cristina and Langenberger, David and Karsch, Dennis and Lenze, Dido and Kube, Dieter and Leich, Ellen and Richter, Gesine and Korbel, Jan and Hoell, Jessica and Eils, Jürgen and Hezaveh, Kebriah and Trümper, Lorenz and Rosolowski, Maciej and Weniger, Marc and Rohde, Marius and Kreuz, Markus and Loeffler, Markus and Schilhabel, Markus and yling, Martin and Hansmann, Martin-Leo and Hummel, Michael and Szczepanowski, Monika and Ammerpohl, Ole and Stadler, Peter F and ... and ICGC Breast Canc Consortium and ICGC MMML-Seq Consortium and Australian Pancreatic Canc Genome and ICGC PedBrain and ICGC Breast Cancer Consortium and Australian Pancreatic Cancer Genome Initiative and Onkologi och Patologi, MV and Lund University and Oncology and Pathology, MV and Lunds universitet
Nature, ISSN 0028-0836, 2013, Volume 500, Issue 7463, pp. 415 - 421
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 6, pp. 520 - 531
This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of... 
FCM | MEDICINE, GENERAL & INTERNAL | THERAPY | PROSPECTIVE RANDOMIZED-TRIAL | CYCLOPHOSPHAMIDE | PROGRESSION-FREE SURVIVAL | RITUXIMAB | CHRONIC LYMPHOCYTIC-LEUKEMIA | COMBINATION | FLUDARABINE | STUDY-GROUP GLSG | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, Mantle-Cell - mortality | Aged, 80 and over | Female | Maintenance Chemotherapy | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Survival Rate | Vidarabine - analogs & derivatives | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Fludarabine | Mantle cell lymphoma | Aged patients | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Clinical trials | Prednisone | Lymphoma | Doxorubicin | Patients | Vincristine | α-Interferon | Cyclophosphamide | Motivation | Remission | Lymphomas | Computer centers | Age | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2007, Volume 25, Issue 5, pp. 579 - 586
Journal Article
Annals of Oncology, ISSN 1569-8041, 03/2013, Volume 24, Issue 3, pp. 561 - 76
Journal Article
Blood, ISSN 0006-4971, 04/2010, Volume 115, Issue 16, pp. 3215 - 3223
Journal Article
Journal Article
Blood, ISSN 0006-4971, 04/2005, Volume 105, Issue 7, pp. 2677 - 2684
Journal Article
Journal Article